These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 33037986)

  • 1. Applications of nanobodies in plant science and biotechnology.
    Wang W; Yuan J; Jiang C
    Plant Mol Biol; 2021 Jan; 105(1-2):43-53. PubMed ID: 33037986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications.
    Wang Y; Fan Z; Shao L; Kong X; Hou X; Tian D; Sun Y; Xiao Y; Yu L
    Int J Nanomedicine; 2016; 11():3287-303. PubMed ID: 27499623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanobodies: From Serendipitous Discovery of Heavy Chain-Only Antibodies in Camelids to a Wide Range of Useful Applications.
    Ji F; Ren J; Vincke C; Jia L; Muyldermans S
    Methods Mol Biol; 2022; 2446():3-17. PubMed ID: 35157266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD38-Specific Biparatopic Heavy Chain Antibodies Display Potent Complement-Dependent Cytotoxicity Against Multiple Myeloma Cells.
    Schütze K; Petry K; Hambach J; Schuster N; Fumey W; Schriewer L; Röckendorf J; Menzel S; Albrecht B; Haag F; Stortelers C; Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2553. PubMed ID: 30524421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
    Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
    J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
    Bannas P; Hambach J; Koch-Nolte F
    Front Immunol; 2017; 8():1603. PubMed ID: 29213270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Nanobodies.
    Muyldermans S
    Annu Rev Anim Biosci; 2021 Feb; 9():401-421. PubMed ID: 33233943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single domain antibody: Development and application in biotechnology and biopharma.
    Yu T; Zheng F; He W; Muyldermans S; Wen Y
    Immunol Rev; 2024 Nov; 328(1):98-112. PubMed ID: 39166870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A guide to: generation and design of nanobodies.
    Muyldermans S
    FEBS J; 2021 Apr; 288(7):2084-2102. PubMed ID: 32780549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Antibody and Nanobody Tools for P2X7.
    Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
    Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobodies as probes to investigate purinergic signaling.
    Eggers M; Rühl F; Haag F; Koch-Nolte F
    Biochem Pharmacol; 2021 May; 187():114394. PubMed ID: 33388283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation, expression and utilization of single-domain antibodies for in vivo protein localization and manipulation in sea urchin embryos.
    Schrankel CS; Gökirmak T; Lee CW; Chang G; Hamdoun A
    Methods Cell Biol; 2019; 151():353-376. PubMed ID: 30948018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.
    Ditlev SB; Florea R; Nielsen MA; Theander TG; Magez S; Boeuf P; Salanti A
    PLoS One; 2014; 9(1):e84981. PubMed ID: 24465459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of Nanobody Nb23.
    Percipalle M; Hunashal Y; Steyaert J; Fogolari F; Esposito G
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level expression of Camelid nanobodies in Nicotiana benthamiana.
    Teh YH; Kavanagh TA
    Transgenic Res; 2010 Aug; 19(4):575-86. PubMed ID: 19862637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.